Guardant Health (GH) Common Equity (2017 - 2026)

Guardant Health (GH) has 10 years of Common Equity data on file, last reported at -$181.1 million in Q1 2026.

• Quarterly Common Equity rose 27.8% year-over-year to -$181.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$181.1 million (up 27.8% YoY) and the FY2025 annual result came in at -$99.3 million, up 28.89% from the prior year.
• Common Equity slipped to -$181.1 million in Q1 2026 per GH's latest filing, from -$99.3 million in the prior quarter.
• The five-year high for Common Equity was $533.0 million in Q1 2022, with the low at -$354.5 million in Q3 2025.
• Average Common Equity over 5 years is $22.9 million, with a median of -$1.6 million recorded in 2024.
• Year-over-year, Common Equity surged 253.27% in 2024 and plunged 18838.31% in 2025.
• Guardant Health's Common Equity stood at $60.2 million in 2022, then surged by 163.68% to $158.7 million in 2023, then sank by 188.0% to -$139.6 million in 2024, then increased by 28.89% to -$99.3 million in 2025, then slumped by 82.34% to -$181.1 million in 2026.
• Business Quant data shows GH's Common Equity at -$181.1 million in Q1 2026, -$99.3 million in Q4 2025, and -$354.5 million in Q3 2025.